###begin article-title 0
The surface-anchored NanA protein promotes pneumococcal brain endothelial cell invasion
###end article-title 0
###begin p 1
S. Uchiyama and A.F. Carlin contributed equally to this paper.
###end p 1
###begin p 2
###xml 11 35 11 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Streptococcus pneumoniae</italic>
###xml 3 9 <span type="species:ncbi:9606">humans</span>
###xml 11 35 <span type="species:ncbi:1313">Streptococcus pneumoniae</span>
###xml 37 40 <span type="species:ncbi:1313">SPN</span>
###xml 251 254 <span type="species:ncbi:1313">SPN</span>
###xml 386 389 <span type="species:ncbi:1313">SPN</span>
###xml 554 557 <span type="species:ncbi:1313">SPN</span>
###xml 685 688 <span type="species:ncbi:1313">SPN</span>
###xml 718 723 <span type="species:ncbi:9606">human</span>
###xml 940 943 <span type="species:ncbi:1313">SPN</span>
###xml 965 971 <span type="species:ncbi:10090">murine</span>
In humans, Streptococcus pneumoniae (SPN) is the leading cause of bacterial meningitis, a disease with high attributable mortality and frequent permanent neurological sequelae. The molecular mechanisms underlying the central nervous system tropism of SPN are incompletely understood, but include a primary interaction of the pathogen with the blood-brain barrier (BBB) endothelium. All SPN strains possess a gene encoding the surface-anchored sialidase (neuraminidase) NanA, which cleaves sialic acid on host cells and proteins. Here, we use an isogenic SPN NanA-deficient mutant and heterologous expression of the protein to show that NanA is both necessary and sufficient to promote SPN adherence to and invasion of human brain microvascular endothelial cells (hBMECs). NanA-mediated hBMEC invasion depends only partially on sialidase activity, whereas the N-terminal lectinlike domain of the protein plays a critical role. NanA promotes SPN-BBB interaction in a murine infection model, identifying the protein as proximal mediator of CNS entry by the pathogen.
###end p 2
###begin p 3
###xml 0 24 0 24 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Streptococcus pneumoniae</italic>
###xml 340 359 340 359 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib15">Koedel et al., 2002</xref>
###xml 361 385 361 385 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib32">van de Beek et al., 2004</xref>
###xml 387 408 387 408 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib34">Weisfelt et al., 2006</xref>
###xml 410 434 410 434 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib33">Weber and Tuomanen, 2007</xref>
###xml 655 669 655 669 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib31">Tuomanen, 1996</xref>
###xml 671 680 671 680 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib12">Kim, 2003</xref>
###xml 886 905 886 905 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib4">C&#225;mara et al., 1994</xref>
###xml 907 929 907 929 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib23">Pettigrew et al., 2006</xref>
###xml 1036 1060 1036 1060 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib28">Shakhnovich et al., 2002</xref>
###xml 1062 1079 1062 1079 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib29">Tong et al., 2002</xref>
###xml 0 24 <span type="species:ncbi:1313">Streptococcus pneumoniae</span>
###xml 26 29 <span type="species:ncbi:1313">SPN</span>
###xml 89 95 <span type="species:ncbi:9606">humans</span>
###xml 513 518 <span type="species:ncbi:9606">human</span>
###xml 772 775 <span type="species:ncbi:1313">SPN</span>
###xml 803 806 <span type="species:ncbi:1313">SPN</span>
###xml 1010 1013 <span type="species:ncbi:1313">SPN</span>
###xml 1107 1110 <span type="species:ncbi:1313">SPN</span>
###xml 1229 1232 <span type="species:ncbi:1313">SPN</span>
Streptococcus pneumoniae (SPN; pneumococcus) accounts for 50% of bacterial meningitis in humans. This often devastating infection carries a 30% mortality rate, and up to half of survivors experience neurological sequelae reflecting a wide spectrum of brain injuries, including cortical neuronal necrosis and hippocampal neuronal apoptosis (Koedel et al., 2002; van de Beek et al., 2004; Weisfelt et al., 2006; Weber and Tuomanen, 2007). To cause meningitis, bloodborne bacteria must first attach to and penetrate human brain microvascular endothelial cells (hBMECs), which is the single-cell layer comprising the majority of the blood-brain barrier (BBB; Tuomanen, 1996; Kim, 2003). The molecular mechanisms underlying the distinct central nervous system (CNS) tropism of SPN are poorly understood. All SPN clinical isolates express the surface-anchored sialidase (neuraminidase) NanA (Camara et al., 1994; Pettigrew et al., 2006) that targets sialic acid residues on host cells and bacterial flora to promote SPN mucosal colonization (Shakhnovich et al., 2002; Tong et al., 2002). Here, we use an isogenic SPN NanA-deficient mutant and heterologous expression of the NanA constructs to probe the contribution of this protein to SPN-hBMEC interactions in vitro and BBB penetration in vivo.
###end p 3
###begin title 4
RESULTS AND DISCUSSION
###end title 4
###begin title 5
###xml 55 73 55 73 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Lactococcus lactis</italic>
###xml 0 3 <span type="species:ncbi:1313">SPN</span>
###xml 55 73 <span type="species:ncbi:1358">Lactococcus lactis</span>
SPN NanA mutant and heterologous expression of NanA in Lactococcus lactis
###end title 5
###begin p 6
###xml 177 194 165 182 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib17">Lock et al., 1988</xref>
###xml 196 215 184 203 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib4">C&#225;mara et al., 1994</xref>
###xml 336 337 316 317 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</italic>
###xml 404 405 380 381 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</italic>
###xml 432 433 408 409 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</italic>
###xml 456 476 432 452 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib27">Scanlon et al., 1989</xref>
###xml 698 716 674 692 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib1">Avery et al., 1944</xref>
###xml 769 787 745 763 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib16">Lanie et al., 2007</xref>
###xml 916 935 888 907 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib36">Winter et al., 1997</xref>
###xml 1059 1067 1027 1035 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1 A</xref>
###xml 1346 1355 1310 1319 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L. lactis</italic>
###xml 1425 1433 1389 1397 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1 B</xref>
###xml 1528 1536 1488 1496 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1 A</xref>
###xml 1642 1651 1602 1611 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L. lactis</italic>
###xml 1653 1661 1613 1621 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1 C</xref>
###xml 162 165 <span type="species:ncbi:1313">SPN</span>
###xml 532 535 <span type="species:ncbi:1313">SPN</span>
###xml 1283 1286 <span type="species:ncbi:1313">SPN</span>
###xml 1336 1347 <span type="species:ncbi:336404">bacterium L</span>
###xml 1506 1509 <span type="species:ncbi:1313">SPN</span>
###xml 1642 1651 <span type="species:ncbi:1358">L. lactis</span>
NanA is a molecule of 1,035 amino acids and approximately107 kD molecular mass containing a C-terminal LP(X)TG anchor motif for sortase-mediated anchoring to the SPN cell wall (Lock et al., 1988; Camara et al., 1994). NanA sialidase activity targets at least three linkage classes of substrates: the alpha-2,6 and alpha-2,3 linkages of N-acetyl-neuraminic acid to galactose and the alpha-2,6 linkages of N-acetyl-neuraminic acid to N-acetyl-galactosamine (Scanlon et al., 1989). To investigate the potential contribution of NanA to SPN interactions with the BBB endothelium, we compared the well-characterized serotype 2 strain clinical isolate D39, which was originally isolated by Avery in 1916 (Avery et al., 1944) and is highly virulent in animal infection models (Lanie et al., 2007), to its isogenic mutant DeltaNanA, which is confirmed to possess a targeted nonpolar mutation that eliminates NanA expression (Winter et al., 1997). Using a fluorescent assay, we found the DeltaNanA mutant to lack sialidase activity present in the WT parent strain D39 (Fig. 1 A). For complementation and gain-of-function analyses, we amplified the NanA gene from the D39 chromosome, cloned it into an expression vector to generate the recombinant plasmid pNanA, and used this to transform the SPN DeltaNanA mutant and nonpathogenic Gram-positive bacterium L. lactis, confirming NanA surface expression by flow cytometry in the latter (Fig. 1 B). Complementation in trans with NanA restored sialidase activity to the SPN DeltaNanA mutant (Fig. 1 A). Furthermore, compared with the empty vector control, pNanA conferred significant sialidase activity to L. lactis (Fig. 1 C).
###end p 6
###begin p 7
###xml 0 86 0 86 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SPN NanA is necessary and sufficient to promote hBMEC invasion and adherence in vitro.</bold>
###xml 241 259 237 255 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Lactococcus lactis</italic>
###xml 337 346 333 342 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L. lactis</italic>
###xml 551 560 543 552 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in trans.</italic>
###xml 607 616 599 608 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L. lactis</italic>
###xml 936 937 928 929 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 0 3 <span type="species:ncbi:1313">SPN</span>
###xml 130 133 <span type="species:ncbi:1313">SPN</span>
###xml 241 259 <span type="species:ncbi:1358">Lactococcus lactis</span>
###xml 337 346 <span type="species:ncbi:1358">L. lactis</span>
###xml 383 386 <span type="species:ncbi:1313">SPN</span>
###xml 480 483 <span type="species:ncbi:1313">SPN</span>
###xml 607 616 <span type="species:ncbi:1358">L. lactis</span>
###xml 628 631 <span type="species:ncbi:1313">SPN</span>
SPN NanA is necessary and sufficient to promote hBMEC invasion and adherence in vitro. (A) Loss of sialidase activity in isogenic SPN DeltaNanA mutant, which is restored by plasmid complementation. (B) Heterologous expression of NanA on the Lactococcus lactis surface as detected by flow cytometry. (C) Gain of neuraminidase activity in L. lactis transformed with plasmid containing SPN NanA. (D) Decreased hBMEC adherence and invasion by DeltaNanA mutant compared with WT parent SPN strain, restored by complementation with a NanA-expressing plasmid in trans. (E) Increased hBMEC adherence and invasion by L. lactis expressing SPN NanA. Sialidase assay performed three times with similar results; representative experiment shown. Adherence and invasion assays performed in triplicate and repeated three times; graphs show cumulative data from all experiments. Error bars represent standard deviation, statistical analysis by Student's t test.
###end p 7
###begin title 8
NanA is necessary and sufficient to promote hBMEC adherence and invasion
###end title 8
###begin p 9
###xml 215 224 215 224 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib13">Kim, 2006</xref>
###xml 399 416 399 416 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib25">Ring et al., 1998</xref>
###xml 427 440 427 440 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Streptococcus</italic>
###xml 442 460 442 460 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib19">Nizet et al., 1997</xref>
###xml 463 479 463 479 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Escherichia coli</italic>
###xml 484 502 484 502 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib11">Huang et al., 1995</xref>
###xml 509 531 509 531 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Haemophilus influenzae</italic>
###xml 533 554 533 554 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib22">Orihuela et al., 2009</xref>
###xml 809 817 805 813 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1 D</xref>
###xml 882 891 878 887 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L. lactis</italic>
###xml 993 1001 989 997 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1 E</xref>
###xml 43 48 <span type="species:ncbi:9606">human</span>
###xml 394 397 <span type="species:ncbi:1313">SPN</span>
###xml 463 479 <span type="species:ncbi:562">Escherichia coli</span>
###xml 509 531 <span type="species:ncbi:727">Haemophilus influenzae</span>
###xml 595 598 <span type="species:ncbi:1313">SPN</span>
###xml 870 873 <span type="species:ncbi:1313">SPN</span>
###xml 882 891 <span type="species:ncbi:1358">L. lactis</span>
Studies of microbial interactions with the human BBB have been greatly facilitated by the development of an immortalized hBMEC line retaining the morphological and functional characteristics of primary endothelium (Kim, 2006). Adherence and intracellular invasion of hBMEC within a membrane-bound vacuole appears to be a common phenotypic property of several CNS bacterial pathogens, including SPN (Ring et al., 1998), group B Streptococcus (Nizet et al., 1997), Escherichia coli K1 (Huang et al., 1995), and Haemophilus influenzae (Orihuela et al., 2009). Using an in vitro assay, we found the SPN DeltaNanA mutant to exhibit a >90% decrease in hBMEC adherence and invasion compared with the WT parent strain D39, a defect that was corrected upon complementation of the mutant with NanA on a plasmid vector (Fig. 1 D; P < 0.001). Conversely, heterologous expression of SPN NanA in L. lactis conferred a >10-fold increase in the bacterium's ability to adhere to and invade the cultured hBMEC (Fig. 1 E; P < 0.001).
###end p 9
###begin title 10
A sialidase inhibitor does not fully block NanA-dependent hBMEC invasion
###end title 10
###begin p 11
###xml 186 187 186 187 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</italic>
###xml 222 241 222 241 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib10">Holzer et al., 1993</xref>
###xml 397 405 397 405 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Fig. 2 A</xref>
###xml 515 530 515 530 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Fig. 2, B and C</xref>
###xml 536 545 536 545 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L. lactis</italic>
###xml 547 555 547 555 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Fig. 2 D</xref>
###xml 700 715 700 715 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Fig. 2, C and D</xref>
###xml 32 35 <span type="species:ncbi:1313">SPN</span>
###xml 510 513 <span type="species:ncbi:1313">SPN</span>
###xml 536 545 <span type="species:ncbi:1358">L. lactis</span>
To further dissect the roles of SPN NanA and its enzymatic activity in mediating pneumococcal interactions with hBMEC, we used the broad-spectrum sialidase inhibitor 2-deoxy-2,3-dehydro-N-acetylneuraminic acid (Neu5Ac2en; Holzer et al., 1993). Neu5Ac2en treatment resulted in a dose-dependent inhibition of NanA sialidase activity with maximal inhibition reaching a plateau between 2.5 and 10 mM (Fig. 2 A). Neu5Ac2en reduced, but did not eliminate, NanA-dependent adherence and invasion of hBMECs in both the SPN (Fig. 2, B and C) and L. lactis (Fig. 2 D) backgrounds. In contrast, the Neu5Ac2en inhibitor had no effect on the low-level baseline hBMEC interactions present in bacteria lacking NanA (Fig. 2, C and D). These findings support a significant contribution of NanA to hBMEC invasion that is independent of its enzymatic activity.
###end p 11
###begin p 12
###xml 0 103 0 103 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Influence of exogenous sialidase or sialidase inhibition on the NanA-mediated hBMEC invasion phenotype.</bold>
###xml 530 539 530 539 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L. lactis</italic>
###xml 555 569 555 569 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A. ureafaciens</italic>
###xml 757 766 753 762 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L. lactis</italic>
###xml 1079 1080 1075 1076 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 141 144 <span type="species:ncbi:1313">SPN</span>
###xml 238 241 <span type="species:ncbi:1313">SPN</span>
###xml 392 395 <span type="species:ncbi:1313">SPN</span>
###xml 530 539 <span type="species:ncbi:1358">L. lactis</span>
###xml 555 569 <span type="species:ncbi:37931">A. ureafaciens</span>
###xml 640 643 <span type="species:ncbi:1313">SPN</span>
###xml 757 766 <span type="species:ncbi:1358">L. lactis</span>
Influence of exogenous sialidase or sialidase inhibition on the NanA-mediated hBMEC invasion phenotype. (A) Dose-dependent inhibition of the SPN NanA sialidase activity by the inhibitor Neu5Ac2en. (B) Dose-dependent partial inhibition of SPN invasion of hBMEC by Neu5Ac2en. (C) Addition of the sialidase inhibitor Neu5Ac2en reduces, but does not eliminate, hBMEC adherence and invasion by WT SPN. (D) Sialidase inhibition reduces, but does not eliminate, the ability of NanA to confer an hBMEC adherence and invasion phenotype to L. lactis. (E) Exogenous A. ureafaciens sialidase does not rescue hBMEC adherence and invasion defects of the SPN DeltaNanA mutant. (F) Exogenous sialidase is not sufficient to promote increased hBMEC adherence and invasion by L. lactis lacking NanA. Sialidase assay performed three times with similar results; representative experiment shown. Adherence and invasion assays performed in triplicate and repeated three times; graphs show cumulative data from all experiments. Error bars represent standard deviation, statistical analysis by Student's t test.
###end p 12
###begin title 13
Exogenous sialidase treatment modestly enhances NanA-dependent hBMEC invasion
###end title 13
###begin p 14
###xml 38 62 38 62 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arthrobacter ureafaciens</italic>
###xml 167 176 163 172 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L. lactis</italic>
###xml 220 235 216 231 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Fig. 2, A and B</xref>
###xml 259 268 255 264 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L. lactis</italic>
###xml 409 424 405 420 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Fig. 2, A and B</xref>
###xml 38 62 <span type="species:ncbi:37931">Arthrobacter ureafaciens</span>
###xml 123 126 <span type="species:ncbi:1313">SPN</span>
###xml 167 176 <span type="species:ncbi:1358">L. lactis</span>
###xml 251 254 <span type="species:ncbi:1313">SPN</span>
###xml 259 268 <span type="species:ncbi:1358">L. lactis</span>
###xml 455 458 <span type="species:ncbi:1313">SPN</span>
Addition of exogenous sialidase (from Arthrobacter ureafaciens) failed to rescue the adherence and invasion defects of the SPN DeltaNanA mutant, and did not stimulate L. lactis hBMEC interactions in the absence of NanA (Fig. 2, A and B). However, for SPN- or L. lactis-expressing NanA, exogenous sialidase stimulated a modest (20-30%), but statistically significant, increase in hBMEC adherence and invasion (Fig. 2, A and B). These results indicate that SPN NanA is both necessary and sufficient to promote efficient bacterial hBMEC adherence and invasion, and suggest that this phenotype is enhanced by, but not dependent on, the sialidase activity of the surface-bound protein.
###end p 14
###begin title 15
Relative contributions of NanA enzyme active site and N-terminal lectinlike domain in pneumococcal hBMEC invasion
###end title 15
###begin p 16
###xml 109 117 109 117 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Fig. 3 A</xref>
###xml 399 421 395 417 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib37">Yesilkaya et al., 2006</xref>
###xml 560 568 552 560 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Fig. 3 A</xref>
###xml 726 734 710 718 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Fig. 3 B</xref>
###xml 826 834 810 818 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Fig. 3 C</xref>
###xml 926 941 910 925 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Vibrio cholerae</italic>
###xml 953 974 937 958 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib7">Crennell et al., 1994</xref>
###xml 984 1001 968 985 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Trypanasoma cruzi</italic>
###xml 1019 1042 1003 1026 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib3">Buschiazzo et al., 2002</xref>
###xml 1310 1327 1294 1311 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib29">Tong et al., 2002</xref>
###xml 1329 1346 1313 1330 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib14">King et al., 2006</xref>
###xml 1681 1689 1661 1669 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Fig. 3 A</xref>
###xml 1807 1815 1779 1787 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Fig. 3 B</xref>
###xml 1851 1859 1823 1831 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Fig. 3 C</xref>
###xml 186 189 <span type="species:ncbi:1313">SPN</span>
###xml 359 362 <span type="species:ncbi:1313">SPN</span>
###xml 845 848 <span type="species:ncbi:1313">SPN</span>
###xml 926 941 <span type="species:ncbi:666">Vibrio cholerae</span>
###xml 1189 1192 <span type="species:ncbi:1313">SPN</span>
###xml 1739 1742 <span type="species:ncbi:1313">SPN</span>
Two targeted deletions were constructed in the recombinant NanA protein and cloned into expression plasmids (Fig. 3 A). These plasmids were then reintroduced by complementation into the SPN DeltaNanA mutant to determine the consequences of each deletion on NanA-mediated hBMEC interactions. First, active site residues essential for the sialidase activity of SPN NanA have recently been identified (Yesilkaya et al., 2006), and we deleted a region containing two of these residues (Glu647 and Arg663) from pNanA to yield the derivative plasmid, pNanADeltaenz (Fig. 3 A). When pNanADeltaenz was used to complement the DeltaNanA mutant, surface expression of the protein was restored to WT levels as assessed by flow cytometry (Fig. 3 B), but, as expected, this expression was not associated with detectable sialidase activity (Fig. 3 C). Second, SPN NanA belongs to a superfamily of concavalin A-like glucanases, including the Vibrio cholerae sialidase (Crennell et al., 1994) and the Trypanasoma cruzi trans-sialidase (Buschiazzo et al., 2002), which contain a sialic acid cleavage domain and a second "lectinlike domain." Because the sialidase activity of NanA is hypothesized to promote SPN colonization by modulating carbohydrate moieties on epithelial cell surfaces and exposing higher affinity receptors (Tong et al., 2002; King et al., 2006), it is conceivable that a NanA lectinlike domain, if indeed functional in promoting binding, could work together with its enzymatic activity in mediating host cell interactions. This laminin G-like domain of NanA is situated toward the N terminus, and we generated a deletion derivative of pNanA lacking this domain, pNanADeltalect (Fig. 3 A). When pNanADeltalect was used to complement the SPN DeltaNanA mutant, WT levels of both surface protein expression (Fig. 3 B) and sialidase enzymatic activity (Fig. 3 C) were restored.
###end p 16
###begin p 17
###xml 0 118 0 118 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Relative contributions of the NanA enzymatic site and N-terminal &#8220;lectinlike&#8221; domains to the hBMEC invasion phenotype.</bold>
###xml 564 573 564 573 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L. lactis</italic>
###xml 206 209 <span type="species:ncbi:1313">SPN</span>
###xml 372 375 <span type="species:ncbi:1313">SPN</span>
###xml 422 428 <span type="species:ncbi:9986">rabbit</span>
###xml 564 573 <span type="species:ncbi:1358">L. lactis</span>
###xml 866 869 <span type="species:ncbi:1313">SPN</span>
Relative contributions of the NanA enzymatic site and N-terminal "lectinlike" domains to the hBMEC invasion phenotype. (A) Scheme for deletion of active site residues and lectinlike domain from recombinant SPN NanA protein; position of protein fragment 318-792 used in subsequent studies. (B) Expression of mutant NanA protein constructs similar to that of NanA on the WT SPN surface as detected by flow cytometry using a rabbit polyclonal antisera against protein fragment 318-792. (C) Deletion of active site region eliminates NanA-induced sialidase activity in L. lactis, whereas deletion of the NanA lectinlike domain has no effect. (D) Targeted elimination of either the NanA enzymatic activity or the N-terminal lectinlike domain allows only partial complementation of the defect in hBMEC adherence, invasion, or transcytosis of the DeltaNanA mutant versus WT SPN. Sialidase and transcytosis assays were performed three times with similar results; representative experiment shown. Adherence and invasion assays were performed in triplicate and repeated at least three times; graphs show cumulative data from all experiments. Error bars represent standard deviation, statistical analysis by analysis of variance with multiple pairwise comparisons.
###end p 17
###begin p 18
###xml 254 262 242 250 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Fig. 3 D</xref>
###xml 403 411 391 399 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1 D</xref>
###xml 519 527 491 499 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Fig. 3 D</xref>
###xml 831 839 799 807 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Fig. 3 D</xref>
###xml 1078 1089 1046 1057 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Fig. 2, A&#8211;F</xref>
###xml 1552 1560 1492 1500 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Fig. 3 D</xref>
###xml 1818 1826 1758 1766 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T. cruzi</italic>
###xml 2004 2025 1944 1965 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib26">Saavedra et al., 1999</xref>
###xml 2027 2054 1967 1994 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib5">Chuenkova and Pereira, 2000</xref>
###xml 2056 2072 1996 2012 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib9">Gao et al., 2002</xref>
###xml 2074 2107 2014 2047 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib6">Chuenkova and PereiraPerrin, 2004</xref>
###xml 1818 1826 <span type="species:ncbi:5693">T. cruzi</span>
The DeltaNanA mutant strains complemented with pNanA, pNanADeltaEnz or pNanADeltaLec were tested in the hBMEC invasion and adherence assays, as well as for their ability to transcytose across a polar hBMEC monolayer from the luminal to basolateral side (Fig. 3 D). In contrast to the full restoration of WT levels of adherence and invasion achieved by complementation with a WT NanA expression plasmid (Fig. 1 D), the pNanADeltaEnz yielded only partial complementation of the phenotypes, to approximately50% WT levels (Fig. 3 D). On statistical analysis, these intermediate levels of hBMEC adherence, invasion, and transcytosis were significantly greater than those observed for the DeltaNanA mutant, although significantly less than those observed for the WT parent strain or the mutant complemented with the intact NanA protein (Fig. 3 D). Thus, NanA sialidase enzymatic activity makes a small, but still demonstrable, contribution to these pneumococcal-hBMEC interactions, which is consistent with the modest effects of sialidase inhibition or exogenous sialidase treatment (Fig. 2, A-F). In contrast, only a very small increase in adherence, invasion, or transcytosis was detected when the DeltaNanA mutant was complemented with pNanADeltaLec (to approximately20% WT levels), and this did not achieve statistical significance when compared with the same mutant transformed with empty vector control. Moreover, the pNanADeltaLec-complemented mutant was significantly less adherent and invasive than the pNanADeltaEnz-complemented strain (P < 0.001; Fig. 3 D). These data reveal a clear role of the N-terminal lectinlike domain in NanA-mediated pneumococcal hBMEC interactions. The dual functionality of pneumococcal NanA in sialic acid cleavage and promotion of host cell binding draws analogy to the activities of T. cruzi trans-sialidase, a virulence factor that can bind to lymphocytes, neurons, and heart endothelial cells to stimulate important host cell activation and proliferation phenotypes (Saavedra et al., 1999; Chuenkova and Pereira, 2000; Gao et al., 2002; Chuenkova and PereiraPerrin, 2004).
###end p 18
###begin title 19
###xml 44 47 <span type="species:ncbi:1313">SPN</span>
NanA peptide or anti-NanA antibody inhibits SPN hBMEC adherence and invasion
###end title 19
###begin p 20
###xml 724 732 724 732 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Fig. 4 A</xref>
###xml 1126 1134 1126 1134 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Fig. 4 B</xref>
###xml 42 45 <span type="species:ncbi:1313">SPN</span>
###xml 582 585 <span type="species:ncbi:1313">SPN</span>
###xml 646 649 <span type="species:ncbi:1313">SPN</span>
###xml 826 829 <span type="species:ncbi:1313">SPN</span>
###xml 953 959 <span type="species:ncbi:9986">rabbit</span>
###xml 1092 1095 <span type="species:ncbi:1313">SPN</span>
The ability of NanA to promote a level of SPN hBMEC adherence and invasion even in the absence of its sialidase activity suggested the protein also serves directly as an adhesin/invasin moeity for the hBMEC surface or can stimulate an up-regulation of hBMEC processes that promote bacterial uptake independent of binding. To further probe these possibilities, an exogenous NanA protein fragment (amino acids 318-792, including key active site residues but lacking sialidase activity) was added to the adherence and invasion assays to determine if its presence blocked or stimulated SPN-hBMEC interactions. We found a dose-dependent inhibition of SPN adherence and invasion of hBMEC by the recombinant NanA protein fragment (Fig. 4 A), which is consistent with a competitive inhibition of cellular receptor(s), suggesting that SPN NanA can function in the capacity of an adhesin/invasin for the brain endothelium. Consistent with this model, addition of rabbit polyclonal antisera raised against the same recombinant NanA protein fragment also produced a concentration-dependent inhibition of SPN hBMEC adherence and invasion (Fig. 4 B).
###end p 20
###begin p 21
###xml 0 95 0 95 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Inhibition of NanA-mediated SPN hBMEC adherence and invasion by recombinant protein or antisera</bold>
###xml 708 709 708 709 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 28 31 <span type="species:ncbi:1313">SPN</span>
###xml 211 214 <span type="species:ncbi:1313">SPN</span>
###xml 261 267 <span type="species:ncbi:9986">rabbit</span>
###xml 388 391 <span type="species:ncbi:1313">SPN</span>
###xml 440 446 <span type="species:ncbi:9913">bovine</span>
###xml 502 508 <span type="species:ncbi:9986">rabbit</span>
Inhibition of NanA-mediated SPN hBMEC adherence and invasion by recombinant protein or antisera. (A) Addition of a recombinant NanA protein fragment (amino acids 318-792) produces a dose-dependent inhibition of SPN hBMEC adherence and invasion. (B) Addition of rabbit polyclonal antisera against the same recombinant NanA protein fragment produces a concentration-dependent inhibition of SPN hBMEC adherence and invasion. Control peptide = bovine serum albumin 5.0 mg/ml; control antibody = polyclonal rabbit antihyaluronidase 1:250 final dilution. Assays were performed three times with similar results; representative assay shown. Error bars represent standard deviation, statistical analysis by Student's t test.
###end p 21
###begin title 22
###xml 14 17 <span type="species:ncbi:1313">SPN</span>
NanA promotes SPN-BBB interaction in vivo
###end title 22
###begin p 23
###xml 466 484 466 484 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib18">Manco et al., 2006</xref>
###xml 1027 1035 1019 1027 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig5">Fig. 5 A</xref>
###xml 1301 1309 1289 1297 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig5">Fig. 5 B</xref>
###xml 66 69 <span type="species:ncbi:1313">SPN</span>
###xml 152 155 <span type="species:ncbi:1313">SPN</span>
###xml 314 317 <span type="species:ncbi:1313">SPN</span>
###xml 367 372 <span type="species:ncbi:10090">mouse</span>
###xml 512 515 <span type="species:ncbi:1313">SPN</span>
###xml 566 572 <span type="species:ncbi:10090">murine</span>
###xml 736 739 <span type="species:ncbi:1313">SPN</span>
###xml 869 872 <span type="species:ncbi:1313">SPN</span>
###xml 1188 1192 <span type="species:ncbi:10090">mice</span>
Lastly, we sought to determine whether the marked contribution of SPN NanA to hBMEC adherence and invasion in vitro translated to increased capacity of SPN to penetrate the BBB in vivo. Our choice of animal model had to exclude the confounding contribution of NanA to sustained bacteremia because a NanA-deficient SPN mutant was recently found to be cleared from the mouse circulation within 24 h of intravenous challenge, whereas the WT parent strain proliferated (Manco et al., 2006). To focus specifically on SPN-BBB interactions, we developed a short-term (4-h) murine intravenous challenge model that incorporated terminal exsanguination by saline perfusion (to eliminate blood contamination), allowing calculation of the ratio of SPN CFU in brain versus blood at the experimental endpoint. We found that at 4 h, the levels of WT D39 and isogenic DeltaNanA mutant SPN in blood were similar, but the median ratio of brain/blood CFU in the WT strain (0.512%) was 16-fold greater than the DeltaNanA mutant (0.031%; P < 0.01; Fig. 5 A). Histopathologic analysis and tissue Gram-stain could identify lancet-shaped diplococci associated with brain endothelium in sections from WT-infected mice; CNS-associated bacteria were scant or absent in those animals infected with the isogenic DeltaNanA mutant (Fig. 5 B).
###end p 23
###begin p 24
###xml 0 48 0 48 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NanA contributes to SPN BBB penetration in vivo.</bold>
###xml 176 177 176 177 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7</sup>
###xml 286 287 282 283 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 800 801 792 793 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 20 23 <span type="species:ncbi:1313">SPN</span>
###xml 128 132 <span type="species:ncbi:10090">mice</span>
###xml 188 191 <span type="species:ncbi:1313">SPN</span>
###xml 420 425 <span type="species:ncbi:10090">mouse</span>
###xml 668 672 <span type="species:ncbi:10090">mice</span>
###xml 701 705 <span type="species:ncbi:10090">mice</span>
###xml 727 730 <span type="species:ncbi:1313">SPN</span>
###xml 1035 1038 <span type="species:ncbi:1313">SPN</span>
###xml 1048 1052 <span type="species:ncbi:10090">mice</span>
NanA contributes to SPN BBB penetration in vivo. (A) Comparison of bacterial counts (CFU) recovered from the blood and brain of mice 4 h after intravenous challenge with 5 x 107 CFU of WT SPN strain D39 or its isogenic DeltaNanA mutant. Results represent a single large experiment with n = 8 per group; all data shown. Because of the technically challenging complete saline perfusion before brain harvesting, individual mouse infections were initiated at staggered timed, with validation of bacterial inocula throughout by CFU counts. Although blood CFU recovered at 4 h did not differ between the two groups (P = 0.37), the ratio of brain CFU/blood CFU in individual mice was significantly higher in mice infected with the WT SPN strain than the DeltaNanA mutant (P < 0.01). Statistics by Student's t test; red line shows median. A repeat experiment performed without saline perfusion and using a 6-h time point yielded similar results (Fig. S1). (B) Representative histopathological examination (100x oil immersion) of brain from WT SPN-infected mice showed Gram-positive cocci in association with brain microvascular endothelium or within the brain parenchyma (arrows); such findings were extremely rare or absent in animals infected with the DeltaNanA mutant. Bar, 15 microM.
###end p 24
###begin title 25
###xml 16 19 <span type="species:ncbi:1313">SPN</span>
Role of NanA in SPN-BBB interactions and the development of meningitis
###end title 25
###begin p 26
###xml 525 542 525 542 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib14">King et al., 2006</xref>
###xml 721 739 721 739 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib2">Braun et al., 2002</xref>
###xml 974 993 970 989 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib36">Winter et al., 1997</xref>
###xml 995 1015 991 1011 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib35">Wellmer et al., 2002</xref>
###xml 1234 1254 1230 1250 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib20">O'Toole et al., 1971</xref>
###xml 53 56 <span type="species:ncbi:1313">SPN</span>
###xml 204 207 <span type="species:ncbi:1313">SPN</span>
###xml 551 554 <span type="species:ncbi:1313">SPN</span>
###xml 651 654 <span type="species:ncbi:1313">SPN</span>
###xml 821 824 <span type="species:ncbi:1313">SPN</span>
###xml 828 832 <span type="species:ncbi:10090">mice</span>
###xml 836 847 <span type="species:ncbi:10141">guinea pigs</span>
We conclude that NanA plays an important role in the SPN invasion of BBB endothelial cells and bacterial entry into the CNS, the critical first step in the pathogenesis of meningitis. The contribution of SPN NanA to hMBEC invasion involves an adhesin function, in which the N-terminal lectinlike domain plays a critical role, and a small but significant contribution of the sialidase activity, which may modify host cell receptors to reveal higher affinity ligands, as previously hypothesized for NanA in nasal colonization (King et al., 2006). After SPN breeches the BBB endothelium, subsequent brain injury is more likely the byproduct of different SPN virulence determinants (e.g., the pore-forming toxin pneumolysin; Braun et al., 2002) or host factors, as previous studies using direct intracerebral installation of SPN in mice or guinea pigs identified no differences between WT and DeltaNanA mutant in meningeal inflammation, hearing loss, or neuronal injury scores (Winter et al., 1997; Wellmer et al., 2002). Nevertheless, a clinical correlation between the magnitude of free sialic acid levels in cerebrospinal fluid during pneumococcal meningitis and risk of adverse neurological sequelae including coma has been reported (O'Toole et al., 1971).
###end p 26
###begin p 27
###xml 215 232 215 232 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib25">Ring et al., 1998</xref>
###xml 234 253 234 253 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib24">Pracht et al., 2005</xref>
###xml 559 576 559 576 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib25">Ring et al., 1998</xref>
###xml 842 863 842 863 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib21">Orihuela et al., 2004</xref>
###xml 23 26 <span type="species:ncbi:1313">SPN</span>
###xml 342 345 <span type="species:ncbi:1313">SPN</span>
###xml 432 435 <span type="species:ncbi:1313">SPN</span>
###xml 628 631 <span type="species:ncbi:1313">SPN</span>
###xml 956 959 <span type="species:ncbi:1313">SPN</span>
###xml 1092 1095 <span type="species:ncbi:1313">SPN</span>
Loss of two additional SPN surface proteins has been previously associated with diminished invasion and transcytosis of cultured hBMEC cells-the fibronectin-binding protein PavA and choline-binding protein A (CbpA; Ring et al., 1998; Pracht et al., 2005). Operating in the context of the low capsule, "transparent" phase variant phenotype of SPN, CbpA binds the laminin receptor to promote hBMEC adhesion. In concert, CpbA presents SPN cell wall phosphorylcholine that attaches to platelet-activating factor receptor on the hMBEC surface, promoting invasion (Ring et al., 1998). Although the high-capsule, "opaque" phenotype of SPN predominates in the bloodstream (transparent forms are readily phagocytosed), the high-frequency switch between the two phase variants is sufficient to reveal a contribution of CbpA to BBB penetration in vivo (Orihuela et al., 2004). The studies of NanA reported in the present manuscript were all performed with inocula of SPN expressing the opaque phenotype. We propose that NanA and CpbA may function synergistically to promote passage of the phase-variant SPN bacterium across the BBB.
###end p 27
###begin p 28
###xml 175 192 175 192 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib30">Tong et al., 2005</xref>
###xml 194 216 194 216 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib37">Yesilkaya et al., 2006</xref>
###xml 64 67 <span type="species:ncbi:1313">SPN</span>
###xml 304 307 <span type="species:ncbi:1313">SPN</span>
The conservation of NanA expression in all clinical isolates of SPN prompted interest in the recombinant protein as a universal vaccine antigen against this leading pathogen (Tong et al., 2005; Yesilkaya et al., 2006), as current conjugate polysaccharide vaccines only target a subset of the most common SPN serotypes. Our identification of NanA function in hBMEC adherence and invasion suggests such immunization strategies could have an added benefit in reducing the risk of meningitis as a secondary complication of invasive infection.
###end p 28
###begin title 29
MATERIALS AND METHODS
###end title 29
###begin title 30

###end title 30
###begin title 31
Bacterial strains and preparation of inocula.
###end title 31
###begin p 32
###xml 190 194 182 186 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">nanA</italic>
###xml 226 245 218 237 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib36">Winter et al., 1997</xref>
###xml 551 560 527 536 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L. lactis</italic>
###xml 593 594 569 570 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</sup>
###xml 907 908 873 874 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 999 1001 965 967 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">nm</sub>
###xml 0 3 <span type="species:ncbi:1313">SPN</span>
###xml 248 251 <span type="species:ncbi:1313">SPN</span>
###xml 304 309 <span type="species:ncbi:4932">yeast</span>
###xml 364 367 <span type="species:ncbi:1313">SPN</span>
###xml 551 560 <span type="species:ncbi:1358">L. lactis</span>
###xml 733 739 <span type="species:ncbi:9986">rabbit</span>
SPN serotype 2 strain D39 (NCTC 7466) and its isogenic D39DeltaNanA mutant were used for these experiments. D39DeltaNanA was constructed by nonpolar insertion-duplication mutagenesis of the nanA gene, as previously described (Winter et al., 1997). SPN cultures were grown in Todd-Hewitt broth (THB) + 2% yeast extract (THY media). For complementation studies, the SPN DeltaNanA mutant was transformed with empty vector control (pDC123), pNanA, or the deletion plasmids pNanADeltalect and pNanADeltaenz, and grown in THY + 2 microg/ml chloramphenicol. L. lactis strain NZ9000 transformed with pENanA or empty vector control (pDCerm) were grown in THB + erythromycin (5 microg/ml). Surface expression of proteins was confirmed using a rabbit polyclonal antisera against NanA protein fragment (318-792), a fluorescent secondary antibody, and flow cytometry. After overnight incubation at 37degreesC, with 5% CO2, bacteria were reinoculated into fresh media, grown to mid-logarithmic growth phase (OD600nm = 0.4), centrifuged at 4,000 rpm for 5 min, washed once with PBS, and then resuspended in the appropriate buffer for use in the assays described inthe following paragraphs.
###end p 32
###begin title 33
Generation of NanA expression plasmids.
###end title 33
###begin p 34
###xml 256 257 256 257 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</sup>
###xml 294 303 294 303 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L. lactis</italic>
###xml 569 570 565 566 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</sup>
###xml 1121 1122 1113 1114 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</sup>
###xml 294 303 <span type="species:ncbi:1358">L. lactis</span>
###xml 487 490 <span type="species:ncbi:1313">SPN</span>
The NanA gene was amplified by PCR from the D39 chromosome using primers NanAUpF (5'-GATTGGAGAAAGGAGAGGGG-3') and NanADownR (5'-CGTATCAGCCTGAATGTCATC-3'), and the resulting amplicon directionally cloned into plasmid pDCerm to yield the expression plasmid pENanA for gain-of-function studies in L. lactis. The amplicon was also subcloned into pDC123, which is identical to pDCerm but bearing a chloramphenicol instead of erythromycin resistance marker, for complementation studies in the SPN DeltaNanA mutant. Critical active site residues of NanA were eliminated from pENanA by inverse PCR using primers NanAenzUp (5'-TGTATTTTGCGCACGTCTATTGTTC-3') and NanAenzDown (5'-GGTTGACTGGAGATCTTCAGGTTG-3'). Blunt end ligation of the amplicon deleted residues 645-662, including 2 amino acids critical for sialidase activity, and the modified, enzyme-dead NanA was subcloned into vector pDC123 to produce pNanADeltaenz, an expression plasmid for complementation analysis using the NanA mutant. To eliminate the N-terminal lectinlike domain of NanA, a similar process of inverse PCR followed by blunt end ligation was performed on pENanA using the primers NanAlecUp (5'-GGTTGAGCTCTCCCCCGAAAG-3') and NanAlecDown (5'-ATGCCAGATGTAACGCATGTGCA-3'). Subcloning of the modified peptide into pDC123 yielded pNanADeltalec, an expression/complementation plasmid containing NanA with a deletion of residues 74-229.
###end p 34
###begin title 35
Sialidase activity assay.
###end title 35
###begin p 36
###xml 48 49 48 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</italic>
###xml 63 64 59 60 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sc>
###xml 204 213 196 205 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L. lactis</italic>
###xml 342 343 330 331 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">9</sup>
###xml 157 160 <span type="species:ncbi:1313">SPN</span>
###xml 204 213 <span type="species:ncbi:1358">L. lactis</span>
A quantitative assay using 4-Methylumbelliferyl-N-acetyl-alpha-d-neuraminic acid sodium salt hydrate (4-MU; Fluka USA) was used to assay sialidase activity. SPN (WT D39 and isogenic DeltaNanA mutant) and L. lactis-expressing NanA constructs were centrifuged, washed once, resuspended in 100 microl 0.1M phosphate citrate buffer (pH 6.5) to 109 CFU/ml. Bacterial suspensions were sonicated (Sonic Dismembrator 550; Thermo Fisher Scientific) on ice for 5 s, followed by 15-s rest intervals x 5 cycles. Sample aliquots of 50 microl were added to individuals wells of a 96-well microtiter plate and mixed with 50 microl of 4-MU diluted to 0.35% in phosphate citrate buffer. The plate was incubated at 37degreesC and fluorescence (excitation 360 nm, emission 460 nm) was recorded every 15 min from time 0 to 1 h, with reported values corrected for the reaction blank containing phosphate citrate buffer alone.
###end p 36
###begin title 37
hBMEC assays.
###end title 37
###begin p 38
###xml 433 434 427 428 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 528 546 522 540 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib8">Doran et al., 2005</xref>
###xml 602 603 584 585 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 1119 1125 <span type="species:ncbi:9986">rabbit</span>
###xml 1277 1283 <span type="species:ncbi:9913">bovine</span>
###xml 1320 1326 <span type="species:ncbi:9986">rabbit</span>
Immortalized hBMEC line hBMEC, a product of SV-40 large T antigen transformation maintaining the morphological and functional characteristics of primary endothelium, was obtained from K.S. Kim (Johns Hopkins University, Baltimore, MD). hBMECs were maintained in RPMI 1640 medium (Life Tech Technologies, Inc.) supplemented with 10% FBS, 10% NuSerum (BD), and 1% MEM nonessential amino acids, and were incubated at 37degreesC in 5% CO2. Bacterial adherence and invasion assays were performed essentially as previously described (Doran et al., 2005) within 24 h of established confluence (approximately105 cells/well) at multiplicity of infection = 10 bacteria/cell and duration 30 min (adherence assays) or 2 h (invasion assays). For a transcytosis assay, hBMEC were grown to confluence on collagen-coated 3 microM pore size Transwell plates (Corning-Costar); 5 x 105 CFU of log-phase SPNs were added to the upper (luminal) chamber, and CFU reaching the lower chamber enumerated at the 4-h time point. For inhibition studies, a recombinant NanA protein fragment (residues 318-792) at 2.5 or 5.0 microg/well or anti-NanA rabbit polyclonal antisera at 1:250 or 1:500 final dilution were added to the adherence and invasion assays as indicated; controls for these experiments were bovine serum albumin (5.0 microg/well) and rabbit polyclonal antihyaluronidase antisera (1:250 dilution), respectively.
###end p 38
###begin title 39
###xml 0 6 <span type="species:ncbi:10090">Murine</span>
###xml 16 19 <span type="species:ncbi:1313">SPN</span>
Murine model of SPN brain endothelial cell invasion.
###end title 39
###begin p 40
###xml 68 69 68 69 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7</sup>
###xml 24 28 <span type="species:ncbi:10090">mice</span>
###xml 77 80 <span type="species:ncbi:1313">SPN</span>
###xml 238 242 <span type="species:ncbi:10090">Mice</span>
###xml 899 904 <span type="species:ncbi:10090">mouse</span>
8-10 wk old male BALB/c mice were injected intravenously with 5 x 107 CFU of SPN D39 or its isogenic D39DeltaNanA mutant. 4 h after injection, blood was collected and serial dilutions plated to enumerate bacterial CFU in the circulation. Mice were then deeply anesthesized using an intraperitoneal injection of ketamine (100 mg/kg) and xylazine (10 mg/kg). Their chests were opened, and blood was cleared by inserting a 23-gauge needle into the left ventricle, perfusing with sterile PBS for 7 min using a peristaltic perfusion pump (P-1; GE Healthcare), and allowing fluid to exit through the right atrium. After perfusion, brains were removed and the hemispheres were separated. One half of the brain was homogenized in PBS, diluted, and plated on THY agar plates to enumerate bacteria tightly adherent to the BBB; the other half was fixed in PBS + 4% PFA for histopathological analysis. A repeat mouse challenge experiment was performed as above, omitting the perfusion step, and using a 6-h rather than 4-h experimental endpoint.
###end p 40
###begin title 41
Assurances.
###end title 41
###begin p 42
All animal experiments were approved by the University of California, San Diego (UCSD) Committee on the Use and Care of Animals and performed using accepted veterinary standards. The UCSD Biosafety Committee approved all protocols for bacteriologic experiments.
###end p 42
###begin title 43
Online supplemental material.
###end title 43
###begin p 44
###xml 240 246 236 242 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig5">Fig. 5</xref>
###xml 32 37 <span type="species:ncbi:10090">mouse</span>
###xml 54 57 <span type="species:ncbi:1313">SPN</span>
Fig. S1 is a repeat intravenous mouse challenge of WT SPN versus isogenic DeltaNanA mutant to quantify bacterial entry into the brain compared with bacterial levels in the blood. This experiment represents a replicate of the study shown in Fig. 5, but omitting the saline perfusion step and using 6 h rather than 4 h endpoint. Online supplemental material is available at .
###end p 44
###begin title 45
Supplementary Material
###end title 45
###begin title 46
[Supplemental Material]
###end title 46
###begin p 47
We gratefully thank Elaine Tuomanen and Justin Thornton for many useful suggestions on the manuscript.
###end p 47
###begin p 48
This research was supported by National Institutes of Health grants AI077780 and HD051796 (V. Nizet) and NS051247 (K.S. Doran), an American Heart Association Career Investigator Award (V. Nizet), and a Burroughs-Wellcome Fund Career Award (K.S. Doran). Work in T.J. Mitchell's laboratory was supported by the Wellcome Trust and the Medical Research Council.
###end p 48
###begin p 49
The authors have no conflicting financial interests.
###end p 49
###begin article-title 50
Studies on the chemical nature of the substance inducing transformation of pneumococcal types: inductions of transformation by a desoxyribonucleic acid fraction isolated from pneumococcus type III.
###end article-title 50
###begin article-title 51
###xml 31 32 31 32 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 35 36 35 36 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
Pneumococcal pneumolysin and H(2)O(2) mediate brain cell apoptosis during meningitis.
###end article-title 51
###begin article-title 52
###xml 77 94 77 94 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Trypanosoma cruzi</italic>
###xml 77 94 <span type="species:ncbi:5693">Trypanosoma cruzi</span>
The crystal structure and mode of action of trans-sialidase, a key enzyme in Trypanosoma cruzi pathogenesis.
###end article-title 52
###begin article-title 53
###xml 21 45 21 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Streptococcus pneumoniae</italic>
###xml 21 45 <span type="species:ncbi:1313">Streptococcus pneumoniae</span>
A neuraminidase from Streptococcus pneumoniae has the features of a surface protein.
###end article-title 53
###begin article-title 54
A trypanosomal protein synergizes with the cytokines ciliary neurotrophic factor and leukemia inhibitory factor to prevent apoptosis of neuronal cells.
###end article-title 54
###begin article-title 55
Chagas' disease parasite promotes neuron survival and differentiation through TrkA nerve growth factor receptor.
###end article-title 55
###begin article-title 56
###xml 21 36 21 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Vibrio cholerae</italic>
###xml 21 36 <span type="species:ncbi:666">Vibrio cholerae</span>
Crystal structure of Vibrio cholerae neuraminidase reveals dual lectin-like domains in addition to the catalytic domain.
###end article-title 56
###begin article-title 57
###xml 40 53 40 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Streptococcus</italic>
Blood-brain barrier invasion by group B Streptococcus depends upon proper cell-surface anchoring of lipoteichoic acid.
###end article-title 57
###begin article-title 58
###xml 4 21 4 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Trypanosoma cruzi</italic>
###xml 4 21 <span type="species:ncbi:5693">Trypanosoma cruzi</span>
The Trypanosoma cruzi trans-sialidase is a T cell-independent B cell mitogen and an inducer of non-specific Ig secretion.
###end article-title 58
###begin article-title 59
Inhibition of sialidases from viral, bacterial and mammalian sources by analogues of 2-deoxy-2,3-didehydro-N-acetylneuraminic acid modified at the C-4 position.
###end article-title 59
###begin article-title 60
###xml 0 16 0 16 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Escherichia coli</italic>
###xml 67 75 67 75 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 80 87 80 87 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 145 148 145 148 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ibe</italic>
###xml 0 16 <span type="species:ncbi:562">Escherichia coli</span>
Escherichia coli invasion of brain microvascular endothelial cells in vitro and in vivo: molecular cloning and characterization of invasion gene ibe10.
###end article-title 60
###begin article-title 61
Pathogenesis of bacterial meningitis: from bacteraemia to neuronal injury.
###end article-title 61
###begin article-title 62
Microbial translocation of the blood-brain barrier.
###end article-title 62
###begin article-title 63
###xml 102 126 102 126 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Streptococcus pneumoniae</italic>
###xml 19 24 <span type="species:ncbi:9606">human</span>
###xml 102 126 <span type="species:ncbi:1313">Streptococcus pneumoniae</span>
Deglycosylation of human glycoconjugates by the sequential activities of exoglycosidases expressed by Streptococcus pneumoniae.
###end article-title 63
###begin article-title 64
Pathogenesis and pathophysiology of pneumococcal meningitis.
###end article-title 64
###begin article-title 65
###xml 61 85 61 85 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Streptococcus pneumoniae</italic>
###xml 61 85 <span type="species:ncbi:1313">Streptococcus pneumoniae</span>
Genome sequence of Avery's virulent serotype 2 strain D39 of Streptococcus pneumoniae and comparison with that of unencapsulated laboratory strain R6.
###end article-title 65
###begin article-title 66
###xml 77 101 77 101 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Streptococcus pneumoniae</italic>
###xml 77 101 <span type="species:ncbi:1313">Streptococcus pneumoniae</span>
Purification and immunological characterization of neuraminidase produced by Streptococcus pneumoniae.
###end article-title 66
###begin article-title 67
Pneumococcal neuraminidases A and B both have essential roles during infection of the respiratory tract and sepsis.
###end article-title 67
###begin article-title 68
Invasion of brain microvascular endothelial cells by group B streptococci.
###end article-title 68
###begin article-title 69
Neuraminidase activity in bacterial meningitis.
###end article-title 69
###begin article-title 70
Tissue-specific contributions of pneumococcal virulence factors to pathogenesis.
###end article-title 70
###begin article-title 71
Laminin receptor initiates bacterial contact with the blood brain barrier in experimental meningitis models.
###end article-title 71
###begin article-title 72
###xml 55 79 55 79 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Streptococcus pneumoniae</italic>
###xml 55 79 <span type="species:ncbi:1313">Streptococcus pneumoniae</span>
Variation in the presence of neuraminidase genes among Streptococcus pneumoniae isolates with identical sequence types.
###end article-title 72
###begin article-title 73
###xml 8 32 8 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Streptococcus pneumoniae</italic>
###xml 8 32 <span type="species:ncbi:1313">Streptococcus pneumoniae</span>
PavA of Streptococcus pneumoniae modulates adherence, invasion, and meningeal inflammation.
###end article-title 73
###begin article-title 74
Pneumococcal trafficking across the blood-brain barrier. Molecular analysis of a novel bidirectional pathway.
###end article-title 74
###begin article-title 75
###xml 4 21 4 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Trypanosoma cruzi</italic>
###xml 4 21 <span type="species:ncbi:5693">Trypanosoma cruzi</span>
###xml 126 131 <span type="species:ncbi:9606">human</span>
The Trypanosoma cruzi trans-sialidase, through its COOH-terminal tandem repeat, upregulates interleukin 6 secretion in normal human intestinal microvascular endothelial cells and peripheral blood mononuclear cells.
###end article-title 75
###begin article-title 76
###xml 31 55 31 55 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Streptococcus pneumoniae</italic>
###xml 31 55 <span type="species:ncbi:1313">Streptococcus pneumoniae</span>
Purification and properties of Streptococcus pneumoniae neuraminidase.
###end article-title 76
###begin article-title 77
###xml 27 51 27 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Streptococcus pneumoniae</italic>
###xml 91 113 91 113 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Neisseria meningitidis</italic>
###xml 118 140 118 140 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Haemophilus influenzae</italic>
###xml 27 51 <span type="species:ncbi:1313">Streptococcus pneumoniae</span>
###xml 91 113 <span type="species:ncbi:487">Neisseria meningitidis</span>
###xml 118 140 <span type="species:ncbi:727">Haemophilus influenzae</span>
###xml 207 212 <span type="species:ncbi:9606">human</span>
Neuraminidase expressed by Streptococcus pneumoniae desialylates the lipopolysaccharide of Neisseria meningitidis and Haemophilus influenzae: a paradigm for interbacterial competition among pathogens of the human respiratory tract.
###end article-title 77
###begin article-title 78
###xml 58 82 58 82 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Streptococcus pneumoniae</italic>
###xml 58 82 <span type="species:ncbi:1313">Streptococcus pneumoniae</span>
###xml 86 96 <span type="species:ncbi:10152">chinchilla</span>
Effect of neuraminidase on receptor-mediated adherence of Streptococcus pneumoniae to chinchilla tracheal epithelium.
###end article-title 78
###begin article-title 79
###xml 30 54 30 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Streptococcus pneumoniae</italic>
###xml 30 54 <span type="species:ncbi:1313">Streptococcus pneumoniae</span>
###xml 83 94 <span type="species:ncbi:10152">chinchillas</span>
Immunization with recombinant Streptococcus pneumoniae neuraminidase NanA protects chinchillas against nasopharyngeal colonization.
###end article-title 79
###begin article-title 80
Entry of pathogens into the central nervous system.
###end article-title 80
###begin article-title 81
Clinical features and prognostic factors in adults with bacterial meningitis.
###end article-title 81
###begin article-title 82
Cellular damage in bacterial meningitis: an interplay of bacterial and host driven toxicity.
###end article-title 82
###begin article-title 83
Clinical features, complications, and outcome in adults with pneumococcal meningitis: a prospective case series.
###end article-title 83
###begin article-title 84
###xml 57 81 57 81 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Streptococcus pneumoniae</italic>
###xml 57 81 <span type="species:ncbi:1313">Streptococcus pneumoniae</span>
###xml 85 91 <span type="species:ncbi:10090">murine</span>
Decreased virulence of a pneumolysin-deficient strain of Streptococcus pneumoniae in murine meningitis.
###end article-title 84
###begin article-title 85
###xml 136 147 <span type="species:ncbi:10141">guinea pigs</span>
A role for pneumolysin but not neuraminidase in the hearing loss and cochlear damage induced by experimental pneumococcal meningitis in guinea pigs.
###end article-title 85
###begin article-title 86
Identification of amino acids essential for catalytic activity of pneumococcal neuraminidase A.
###end article-title 86
###begin p 87
###xml 190 191 190 191 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</italic>
###xml 220 244 220 244 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Streptococcus pneumoniae</italic>
###xml 115 120 <span type="species:ncbi:9606">human</span>
###xml 215 218 <span type="species:ncbi:1313">SPN</span>
###xml 220 244 <span type="species:ncbi:1313">Streptococcus pneumoniae</span>
Abbreviations used: BBB, blood-brain barrier; CbpA, choline-binding protein A; CNS, central nervous system; hBMEC, human brain microvascular endothelial cell; Neu5Ac2en, 2-deoxy-2,3-dehydro-N-acetylneuraminic acid; SPN, Streptococcus pneumoniae.
###end p 87

